2016 ASCO Meeting Highlights in Pancreatic Cancer

Advances in Immuno-Oncology: Vaccine Plus Checkpoint Inhibitor Active in Pancreatic Cancer
Begin

Targeting Hyaluronan as a Novel Treatment Approach to Pancreatic Cancer
Begin

Simplified LV5FU2 Plus Nab-paclitaxel is Promising for Pancreatic Cancer
Begin

Advances in Immuno-Oncology: Combination BTK and Checkpoint Inhibitor Active in Pancreatic Cancer
Begin

A New Standard of Care: GEMCAP as Adjuvant Treatment for Early-Stage Pancreatic Cancer
Begin

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved